Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Smoldering Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1

Interventions

Standard of Care 72Educational Status 60Methods 55Interviews as Topic 55Early Intervention, Educational 53Practice Guidelines as Topic 52Exercise 50Blood Specimen Collection 49Magnetic Resonance Spectroscopy 48Surveys and Questionnaires 47Specimen Handling 40Radiosurgery 31Palliative Care 24Radiotherapy 23Biopsy 20Magnetic Resonance Imaging 16Patient Navigation 15Resistance Training 14Counseling 14Exercise Test 13Diet Therapy 13Therapeutics 11Health Promotion 11Surgical Procedures, Operative 10Referral and Consultation 10Radiation Dose Hypofractionation 10Proton Therapy 10Drug Therapy 10X-Rays 9Telemedicine 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Curcumin × 90 days × Clear all
NCT05640843 2026-04-16

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
180 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡